Abstract:Hepatocellular carcinoma (HCC) is one of the most common types of human malignancy worldwide, which is becoming increasingly resistant to traditional drug treatments. Puerarin combined with 5-fluorouracil (5-FU) may be a useful treatment for liver cancer. The primary aim of the present study was to determine whether combined treatment with 5-FU and puerarin is more effective against the hepatocellular carcinoma (HCC) cell line, SMMC7721, than treatment with 5-FU or puerarin alone. The growth inhibition of SMMC7721 cells by puerarin or 5-FU alone or in combination was determined by the Cell Counting Kit-8 assay, in vitro. Apoptotic morphological features and the percentage of apoptotic cells were detected using Hoechst 33258 staining and an Annexin V/PI apoptosis kit, respectively. In addition, a tumor xenograft model was established in nude mice using SMMC7721 cells. Puerarin and 5-FU alone or in combination were injected into the mice, and the inhibition of tumor growth was evaluated by monitoring tumor volume and weight. Treatment with 6,400 or 640 mu M 5-FU resulted in growth inhibition of 95.56 +/- 0.81 and 75.91 +/- 3.54%, respectively. The combination index values were <1 when the fraction of affected cells was between 0.2555 and 0.7420. Furthermore, the percentage of apoptotic cells was markedly increased in the combined treatment group when compared with that of the individual treatment groups, in vitro and in vivo. Individual treatment with puerarin resulted in a tumor volume inhibition rate (IR) of 70.58% and a tumor weight IR of 46.20%. Treatment with 5-FU was found to decrease the tumor volume by 76.26% and tumor weight by 49.86%. In the combined treatment group, the tumor volume and weight IRs were 93.11 and 75.21%, respectively. A marked increase in the inhibition of. tumor growth and the number of apoptotic cells in response to combined treatment with puerarin and 5-FU was identified with no observed liver or renal toxicity. These results suggest that puerarin and 5-FU exhibit a synergistic treatment effect on the HCC SMMC7721 cell line.

Synergistic effects of nimesulide and 5-fluorouracil on tumor growth and apoptosis in the implanted hepatoma in mice.

Polyunsaturated Fatty Acids Augment Tumoricidal Action Of 5-Fluorouracil On Gastric Cancer Cells By Their Action On Vascular Endothelial Growth Factor, Tumor Necrosis Factor-Alpha And Lipid Metabolism Related Factors

Synergistic Inhibitory Effect of Nimesulide in Combination with 5-Fluorouracil on Gastric Cancer Cells and Its Possible Mechanisms

Melatonin Synergizes the Chemotherapeutic Effect of 5‐fluorouracil in Colon Cancer by Suppressing PI3K/AKT and NF‐κB/iNOS Signaling Pathways

Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice

5-Fluorouracil Nanoparticles Inhibit Hepatocellular Carcinoma Via Activation of the P53 Pathway in the Orthotopic Transplant Mouse Model

Synergistic effects of β-aescin and 5-fluorouracil in human hepatocellular carcinoma SMMC-7721 cells

Luteolin synergizes the antitumor effects of 5-fluorouracil against human hepatocellular carcinoma cells through apoptosis induction and metabolism

Synergistic Effect of Triptolide Combined with 5-Fluorouracil on Colon Carcinoma.

Synergistic effect of puerarin and 5-fluorouracil on hepatocellular carcinoma.

Enhanced Proliferation Inhibition and Apoptosis in Glioma Cells Elicited by Combination of Irinotecan and Imatinib

Synergistic Effect of Honokiol and 5‐fluorouracil on Apoptosis of Oral Squamous Cell Carcinoma Cells

Synergistic Effects of TOR Combined with EADM on Growth and Apoptosis in Human Lung Cancer Cell Lines A549 and H1299

Sep Enhanced The Antitumor Activity Of 5-Fluorouracil By Up-Regulating Nkg2d/Mica And Reversed Immune Suppression Via Inhibiting Ros And Caspase-3 In Mice

[Synergistic Use of Epidermal Growth Factor and 5-Fluorouracil for the Treatment of Human Colorectal Cancer in BALB/C Nude Mice Subcutaneous Xenograft Model].

Synergistic antitumor effect of puerarin combined with 5-fluorouracil on gastric carcinoma

Synergistic Antitumor Effect of 5-Fluorouracil Combined with Constituents from Pleurospermum Lindleyanum in Hepatocellular Carcinoma SMMC-7721 Cells.

Cooperative Inhibitory Effect of Sinomenine Combined with 5-Fluorouracil on Esophageal Carcinoma

Synergism Between a Sirna Targeted to Survivin and 5-FU in Inhibiting MCF-7 Cell Proliferation in Vitro.

Synergistic effect of mTOR inhibitor rapamycin and fluorouracil in inducing apoptosis and cell senescence in hepatocarcinoma cells.

Effect of Nimesulide on Proliferation and Apoptosis of Human Hepatoma Smmc-7721 Cells